In this context, we and others demonstrated that, indeed, Ca2+/CaM binds to and regulates ErbB2 and its downstream signaling pathways, as CaM inhibition or deletion of the CaM binding sites inhibit ErbB2-mediated signaling, decreasing tumor cells proliferation [66,67]. This evidence concerns the gene CALM3 and neoplasm.